AI × Life Sciences

Operators and builders at the frontier of AI × life sciences.

We advise. We embed. We build.

Advisory for investors who need conviction. Fractional leadership with equity alignment. Venture building from zero. All at the convergence of biotechnology and artificial intelligence.

// Our Team

Operating Partners

Proven C-suite talent with deep health-tech expertise

Bob Battista

Bob Battista

Head of Commercial, Salt AI

Life sciences go-to-market • Medical intelligence platforms • Commercial strategy • Enterprise AI adoption

Sibel Sayiner

Sibel Sayiner

VP, Business Operations & Analytics, Marley Medical

(prev. BCG, Propeller Health)

Digital health ops • Data-driven commercialization • Chronic disease virtual care • Payer/provider strategy

Stuart John

Stuart John

First American

Enterprise data platforms • Title & escrow tech • Large-scale systems modernization

Syuzi Pakhchyan

Syuzi Pakhchyan

Head of Innovation & Emerging Experiences, Target

(prev. Design Director, BCG Digital Ventures)

Wearable tech & emerging interfaces • Experience design • Retail innovation • Fashion–technology convergence

Amy Zhang

Amy Zhang

Marketing Strategy & Growth

(formerly Senior Growth Architect, BCG Digital Ventures)

Growth marketing • Go-to-market for SaaS • Digital experiments & performance • Mission-driven brand strategy

Bob Battista

Bob Battista

Head of Commercial, Salt AI

Life sciences go-to-market • Medical intelligence platforms • Commercial strategy • Enterprise AI adoption

Sibel Sayiner

Sibel Sayiner

VP, Business Operations & Analytics, Marley Medical

(prev. BCG, Propeller Health)

Digital health ops • Data-driven commercialization • Chronic disease virtual care • Payer/provider strategy

Stuart John

Stuart John

First American

Enterprise data platforms • Title & escrow tech • Large-scale systems modernization

Syuzi Pakhchyan

Syuzi Pakhchyan

Head of Innovation & Emerging Experiences, Target

(prev. Design Director, BCG Digital Ventures)

Wearable tech & emerging interfaces • Experience design • Retail innovation • Fashion–technology convergence

Amy Zhang

Amy Zhang

Marketing Strategy & Growth

(formerly Senior Growth Architect, BCG Digital Ventures)

Growth marketing • Go-to-market for SaaS • Digital experiments & performance • Mission-driven brand strategy

// How We Work

Three models, one mission

01

Advisory

Due diligence that goes beyond the deck

We've evaluated 50+ computational biology platforms, AI-enabled drug discovery companies, and clinical tech assets for PE and VC investors. Our diligence includes technical architecture reviews, primary research, and commercial viability assessments.

Deliverables

  • Commercial & technical due diligence
  • AI readiness audits and transformation roadmaps
  • Strategic sector analyses with primary research
  • Board presentations and investment memos

Typical: 2-4 weeks, fixed scope

02

Operators

Principals with P&L experience, embedded with equity alignment

We've run commercial organizations, closed enterprise deals, and built GTM motions in life sciences and AI companies. We embed for 100-day sprints with skin in the game—because we only win when you win.

Deliverables

  • Fractional CCO / CRO / CSO roles
  • 100-day transformation sprints
  • GTM strategy → execution → closed pipeline
  • Team building and organizational design

Typical: 4-6 months, retainer + equity

03

Incubation

We co-found at the frontier

When we see a problem worth solving, we build. We've taken companies from napkin sketch to paying customer in under 90 days. We bring capital-efficient execution and deep domain networks.

Deliverables

  • Problem validation and market research
  • Zero to MVP in 90 days, <$250K total spend
  • Corporate formation and fundraising support
  • Studio co-founder model with sweat equity

Current focus: AI × women's health, computational biology tools

// Engagement Models
01

Retainer + Equity

Our preferred model for long-term operator partnerships

Typical: $10-20K/mo + 0.5-2% equity

02

Fixed-Scope Project

For targeted diligence and strategic analyses

Typical: 2-6 weeks, $25-75K

03

Studio Co-found

Sweat equity for ventures we believe in

Typical: Significant equity, milestone-based

We're not a 200-person consultancy.

We don't staff junior analysts on your project.

We're not generalists playing in life sciences.

You get principals who've operated in the roles you're trying to fill.

People who've built the APIs, closed the deals, and presented to the boards.

// Let's Connect

Let's talk

Whether you need conviction on a deal, hands-on operators with skin in the game, or a co-founding partner at the frontier—we're here.

Reach Out